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Frequent ventricular premature complexes, complex
ventricular ectopic activity and asymptomatic ventric-
ular tachycardia are common to both hypertrophic and
dilatedcardiomyopathy; in both conditions, sudden death
is a common occurrence. Asymptomaticyoung patients
with hypertrophic cardiomyopathy who have a family
history and a high incidenceof ventricular arrhythmias
have a particularly high incidence of sudden death. In
patients with hypertrophic cardiomyopathy, efforts to
attribute sudden death to the cardiac index, left ven-
tricular end-diastolic pressure, left ventricular outflow
obstruction, ejection fraction, age, symptomatic state
and septal thicknesshave been unrewarding. Myocardial
hypertrophy and disordered myocardial cell arrange-
ment are the likely substrates for the development of
ventricular arrhythmias in hypertrophic cardio-
myopathy. Ventricular fibrillation preceded by ventric-
ular tachycardia appears to be the terminal event in most
patients who die suddenly. In some patients, cardiac
asystole is the terminal event.
Classification of the disorders affecting heart muscle has
been hampered by diverse opinions concerning conditions
warranting inclusion. We have adopted the World Health
Organization's recommendation dividing heart muscle dis-
ease into two primary groups . Group I comprises heart
muscle disease of known cause or association with disorders
of other systems , namely , coronary artery disease , hyper-
tension , valvular and congenital heart disease, infectious
disease, systemic disease , metabolic disease, heredofamilial
disorders and sensitivity and toxic reactions. Group 2 com-
prises heart muscle disease of unknown origin , and only in
this group would the term "cardiomyopathy" be applied
(1). Cardiomyopathy was defined as "heart muscle disease
of unknown cause " and divided into three groups: hyper-
trophic , dilated (congestive) and restrictive . Because the
restrictive type is so rare, no studies on its role in sudden
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Additional factors playing a role in the development
of the substrate for sudden death in patients with hy-
pertrophic cardiomyopathy vary in importance on an
individual basis. These factors include narrowing of sep-
tal arteries and the artery to the atrioventricular node,
preservation of fetal anatomy with dispersion in the
atrioventricular node and His bundle, fibrosis of the
sinus node, clefts in the septum, multiple atrioventric-
ular pathways and massive myocardial infarction.
Patients with dilated cardiomyopathy appear to have
the highest incidence of ventricular arrhythmias of any
disease yet studied. The substrate for the development
of ventricular arrhythmias in these patients appears to
be myocardial hypertrophy and myocardial fibrosis. De-
spite some conflicting evidence, the incidence of sudden
death in dilated cardiomyopathy appears to be highest
when the ejection fraction is reduced and there is a high
incidence of ventricular arrhythmias.
(J Am Coil CardioI1985;5:185B-189B)
death have been reported. Consequently, this discussion will
be limited to the hypertrophic and dilated types.
Both of these conditions have one factor in common,
though they are strikingly different in most other respects .
The common factor is the presence of muscle hypertrophy .
It has been noted earlier in this conference that myocardial
hypertrophy is almost invariably present in patients who die
suddenly. The question could be asked , " Is hypertrophy
the major problem causing the high incidence of sudden
death in these two conditions?" Probably not, but clearly
it is one of the important substrates to be considered.
Hypertrophic Cardiomyopathy
Cardiac arrhythmias and sudden death. This heart
muscle disease of supernormal systolic and abnormal dia-
stolic function has an established association with sudden
death . Teare (2) in his original report noted that eight of
his nine patients died suddenly. James and Marshall (3)
reported on 22 subjects who died suddenly and unexpectedly
with what was termed asymmetric hypertrophy of the heart .
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A remarkable variety of abnormal findings were described
and documented. These included deep septal clefts in 7
hearts , narrowed coronary arteries in 10 hearts, sinus node
fibrosis in 12 hearts, narrowing of the atrioventricular (AV)
nodal artery in many hearts and thinning of the His bundle
in 3 hearts. Most striking was the presence of fetal-type
tissue in the AV node and His bundle in 13 hearts. They
noted that the dense sclerotic fibrosis of the same node was
not consistent with the vascular supply and was indicative
of abnormal collagen . They also noted that the changes in
the central fibrous body were similar to those in patients
with the Wolff-Parkinson-White syndrome and support the
possibility that there could be enhanced speed of activation
in the interventricular septum and ventricles.
In support of these anatomic findings was the report of
Ingham et al. (4). Thirteen patients with hypertrophic car-
diomyopathy underwent electrophysiologic study, and a high
incidence of arrhythmia and conduction abnormalities was
noted. Although no intraatrial conduction delay was present,
7 of 12 patients had dual AV nodal responses , and 10 of
12 had prolonged His-Purkinje conduction as evidenced by
a prolonged HV interval. A study of sudden death in 26
patients with hypertrophic cardiomyopathy without func-
tional limitations originated with Maron et al. (5). All pa-
tients in their study died suddenly. Their ages varied from
8 to 49 years (mean 18). Twenty-three of the 26 were youn-
ger than 25 years of age; there were 19 men and 7 women.
Half of the group died during or immediately after moderate
to severe physical exertion. The electrocardiogram was ab-
normal in all 19 patients studied before death . Four patients
were noted to have documented ventricular fibrillation just
after their collapse . It is noteworthy that one-third of the
26 patients had a family history of sudden cardiac death in
a first degree relative.
In recent years, the high incidence ofcardiac arrhythmia
in hypertrophic cardiomyopathy has been documented by a
number of investigators . McKenna et al. (6) studied 30
patients who underwent both treadmill exercise and 48 hour
ambulatory electrocardiographic monitoririg. Only 1 patient
had no arrhythmia; 14 patients (46%) had paroxysmal supra-
ventricular tachycardia or atrial fibrillation, 13 patients (43%)
had multiform or paired ventricular premature complexes
and 8 patients (26%) had nonsustained ventricular tachy-
cardia. With exercise testing, 18 (60%) of the patients had
ventricular premature complexes and 3 patients (10%) had
paired ventricular premature complexes. It was noted that
no hemodynamic or echocardiographic measurement pre-
dicted these serious ventricular arrhythmias.
McKenna et al . (6) posed the question of the mechanism
of sudden death in patients with hypertrophic cardio-
myopathy, recognizing that serious ventricular arrhythmias
seemed to predispose the patient to sudden death. The pos-
sibility of rapid AV transmission by way of accessory path-
ways with rapid ventricular response and ventricular fibril-
lation was considered, but in a larger group of 226 patients
with hypertrophic cardiomyopathy, they had noted the Wolff-
Parkinson-White syndrome in only 3 and none of their smaller
group of 30 patients had evidence of pre-excitation. Other
mechanisms considered were ischemia due to systolic
compression of the septal perforator vessels shown to be
present in hypertrophic cardiomyopathy, in addition to nar-
rowing of some of the small septal arteries noted by James
and Marshall (3). In the study of McKenna et al., six of
the eight patients who had ventricular tachycardia had brady-
cardia just before the ventricular tachycardia. The other two
had heart rates between 100 and 110 beats/min. The fre-
quency of multiform and paired ventricular premature com-
plexes was associated with ventricular tachycardia, and the
two patients who died within 6 months had frequent mul-
tiform and paired ventricular premature complexes. No clin-
ical, echocardiographic , electrocardiographic or hemody-
namic feature including family history, septal thickness or
elevated left ventricular end-diastolic pressure , proved to be
a reliable predictor of serious ventricular arrhythmias.
In 1981, Maron et al. (7) reported on 99 patients who
were studied by ambulatory electrocardiography. Ventric-
ular arrhythmias of grade 3 and above were noted in 66%
of patients, including 19% with asymptomatic ventricular
tachycardia. The clinical outcome was assessed 3 years after
the 24 hour monitoring. Of the 84 patients who did not
undergo surgery, 6 died suddenly or had a cardiac arrest.
One died of progressive heart failure and 77 survived. The
occurrence of a sudden cardiac catastrophe was more com-
mon in patients with asymptomatic ventricular tachycardia
of brief duration (24%) than in patients without ventricular
tachycardia (3%). The finding of ventricular tachycardia on
24 hour monitoring was considered to have identified a
subgroup at high risk for sudden death, namely, an 8.6%
annual mortality rate.
Another study of arrhythmias in hypertrophic cardio-
myopathy originated with McKenna et al. (8). A more pro-
longed period , 72 hours, of ambulatory monitoring was
performed in 86 unselected patients wtih hypertrophic car-
diomyopathy. Twenty-three patients had at least one episode
of supraventricular tachycardia and 24 patients had ventric-
ular tachycardia (10 had more than three episodes). The
patients were followed up for a mean of 2.6 years (range I
to 4). Seven patients died suddenly. Of these, five had
exhibited multiform and paired ventricular premature beats
and ventricular tachycardia . These arrhythmias had a sig-
nificant association with sudden death , while supraventric-
ular tachycardia did not. Patients who died suddenly were
older and had more symptoms than did the survivors. Three
had a family history of hypertrophic cardiomyopathy and
sudden death . McKenna and coworkers noted that in their
series of 254 patients, 32 died suddenly. They were rela-
tively young (range 7 to 67 years, mean 37) and often were
asymptomatic. Seven patients who died in the current study
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were older (mean 58 years) and four of the seven had severe
functional limitation. They noted that patients who die sud-
denly are not a homogeneous group . They include both
children and elderly individual s, those who are asympto-
matic and severely limited, those with massive and with
minimal hypertrophy and those with a left ventricular out-
flow gradient and abnormal filling pressure and those with-
out these abnormalities . Although the investigators believed
that a causal relation of cardiac arrhythmia to sudden death
would be difficult to establish , the evidence supported the
view that treatment of serious ventricular arrhythmias in
hypertrophic cardiomyopathies should be explored.
Prognosis and mechanism of sudden death. In another
study from the Hammersmith group, McKenna, et al. (9)
addressed prognosis in hypertrophic cardiomyopathy. Two
hundred fifty-four patients with hypertrophic cardio-
myopathy were followed up from I to 23 years (mean 6).
The study disclosed 58 deaths, 32 of them sudden. One
hundred ninety-six survivors were compared with the 32
patients who died suddenly and with the 38 who died sud-
denly or with heart failure. The combination of a young age
(:514 years), syncope at diagnosi s, severe dyspnea at last
follow-up and a family history of hypertrophic cardio-
myopathy and sudden death best predicted the possibility
of sudden death. A malignant family history was associated
with a poor prognosis. especially in young patients. Patients
who had a diagnosi s in childhood were usually asympto-
matic. had an unfavorable family history and a 5.9% annual
mortality rate. In those aged 15 to 45 years at the time of
diagnos is. there was a 2.5% annual mortality rate , and syn-
cope was the only prognostic feature . Among those diag-
nosed between 45 and 60 years, dyspnea and chest pain
were more common in the patients who died, and the annual
mortality rate was 2.6%. It was noted that a poor prognosis
was better predicted by the history at the time of diagnosis
and by changes in symptoms during follow-up than by
electrocardiographic or by hemodynamic measurement. In
young patients. sudden death was unrelated to severe func-
tionallimitation, elevated filling pressures or left ventricular
outflow obstruction. In older patients, the mechanism of
death may be a worsening hemodynamic state , but the un-
derlying mechanism did not seem to be hemodynamic in
most patients. The authors indicate that it seems unreason -
able to assume that the mechanism of sudden death is the
same in all patients with hypertrophic cardiomyopathy . Con-
siderations are those of cardiac asystole , massive myocardial
infarction, rapid AV conduction through an accessory path-
way degenerating to ventricular fibrillation and increased
outflow gradient or tachycardia with a sudden decrease in
cardiac output.They noted that although it is unproven , they
suspect that ventricular arrhythmias are the antecedent of
most sudden deaths. In their series, 55% had died suddenly
and there had been associated syncope. Maron et a1. (5)
also supported the probability that sudden death was most
likely due to a primary arrhythmia. They noted that the most
extensive disorganization of myocardial cells was found in
young asymptomatic patients who died suddenly.
Role of ventricular hypertrophy and impaired ven-
tricular function. The role of left ventricular hypertrophy
in hypertrophic cardiomyopathy was reviewed by McKenna
et al. (10). One hundred patients were followed up for a
mean of 8 years (range 5 to 20) . In one-fourth ofthe patients,
left ventricular hypertrophy progressed and if it was asso-
ciated with chest pain , the possibility of sudden death was
great. They concluded that left ventricular hypertrophy in
patients who die suddenly is usually severe , but occasion-
ally it is minimal. Newman et al. (11) noted the relation
of left ventricular function to sudden death in hypertrophic
cardiomyopathy. Patients who died suddenly had the com-
bination of a low peak filling rate , large end-systolic volume
and high ejection fraction . The angiographic finding of a
hyperkinetic left ventricle with impaired filling was a marker
for patients at particular risk of sudden death .
Dilated Cardiomyopathy
Arrhythmias and sudden death. In recent years, a
number of studies have emerged documenting the high in-
cidence of serious ventricular arrhythmias and significant
risk of sudden death in dilated cardiomyopathy. Huang et
at. (12) studied 24 men and 11 women aged 22 to 72 years.
Complex ventricular premature beats (Lown grades 3, 4 and
5) were presented in 93% and 21 patients (60%) had non-
sustained ventricular tachycard ia (3 to 46 beats) with rates
of 75 to 210 beats/min. No difference was observed between
patients with and without ventricular tachycardia in regard
to presenting symptoms, functional classification, electro-
cardiographic findings, heart size on chest X-ray film, car-
diac index, left ventricular end-diastolic pressure or ejection
fraction . Patients with ventricular tachycardia were noted
to be among the older patients in the group . During an
observation period that ranged from 4 to 74 months (mean
34 ± 17), two patients died suddenly. one with and one
without ventricular tachycardia, a third died from congestive
heart failure and a fourth died from sepsis . It was concluded
that the incidence of ventricular arrhythmia was high in
dilated cardiomyopathy, that ventricular tachycardia is fre-
quent and nonsustained and that there is no correlation of
ventricular tachycardia with clinical and hemodynamic find-
ings. In this relatively short-term follow-up study , the pres-
ence of ventricular tachycardia did not appear to predict
prognosis.
Ventricular arrhythmias and left ventricular dys-
function. Von Olshausen et a1. (13) performed 24 hour
ambulatory monitoring of the electrocardiogram in 60 pa-
tients . All patients had a left ventricular ejection fraction of
less than 0.55, and it was less than 0.40 in 39 patients .
Ventricular premature complexes were noted in all patients,
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were moderately frequent in 40% and were frequent in 42%.
Multiform ventricular premature complexes were present in
95%, pairs in 78% and nonsustained ventricular tachycardia
(3 to 19 beats) in 42% of patients. Eight patients had more
than five episodes daily of ventricular tachycardia. The pa-
tients with atrial fibrillation had the same frequency and
grade of ventricular arrhythmia as those with sinus rhythm.
Patients with infrequent and frequent ventricular premature
complexes could not be differentiated on the basis of clinical
or hemodynamic findings. The mean values of the New
York Heart Association functional class, cardiac index, left
ventricular end-diastolic pressure and ejection fraction were
significantly different in patients with and without ventric-
ular tachycardia. During a follow-up period of 5 to 12 months,
seven patients died. All had an ejection fraction of less than
0.40. Four patients who died of congestive heart failure
were noted to have ventricular tachycardia recorded on am-
bulatory monitoring. Ventricular tachycardia was present in
only one of three patients who died a sudden cardiac death.
Von Olshausen et aI. (13) indicated that the number and
complexity of ventricular premature complexes in dilated
cardiomyopathy are greater than in any other cardiac disease
reported thus far. In their studies, patients with ventricular
tachycardia have more impairment of left ventricular func-
tion than do patients without ventricular tachycardia. They
consider ambulatory monitoring to be of questionable help
in identifying patients at increased risk of sudden death and
note that previous studies have showed the heart size and
functional classification at the time of diagnosis are impor-
tant indicators of prognosis. They also note that in patients
with coronary artery disease and aortic valve disease, the
complexity of ventricular premature complexes correlates
with ventricular function. If episodes of nonsustained ven-
tricular tachycardia on ambulatory monitoring really playa
role in determining prognosis in dilated cardiomyopathy,
we would expect the occurrence of complex ventricular
arrhythmias to correlate with the degree of ventricular im-
pairment. Huang et aI. (12), however, could not detect any
relation between hemodynamic indexes and the occurrence
of ventricular tachycardia. The study of Von Olshausen et
aI. (13), however, disclosed a significant «0.01) difference
in cardiac index, diastolic pressure and ejection fraction
between those with and without ventricular tachycardia.
Constansa-Norton et aI. (14) studied 55 patients with
dilated cardiomyopathy using 24 hour electrocardiographic
ambulatory monitoring, echocardiography, radionuclide
ventriculography, cardiac catheterization and endomyocar-
dial biopsy. Thirty-five patients (64%) had complex ven-
tricular premature complexes. Two hundred seventy-two
episodes of ventricular tachycardia were noted among 22
patients. No difference was noted in functional status, elec-
trocardiogram, cardiac index, pulmonary capillary wedge
pressure, ejection fraction or left ventricular dimensions
between patients with and without ventricular tachycardia.
Endomyocardial biopsy did not differentiate and clinical and
hemodynamic deterioration did not correlate. Nine patients
died, four were noted to have ventricular tachycardia and
five were without ventricular tachycardia.
Meinertz et al. (J5) also studied the significance of ven-
tricular arrhythmias in idiopathic dilated cardiomyopathy.
Seventy-four patients were studied by 24 hour ambulatory
electrocardiography. Patients were followed up from 2 to
21 months (mean II). Complex ventricular premature com-
plexes (Lown grades 3 and 4) were noted in 87% of patients.
Forty-nine percent of the patients had nonsustained ven-
tricular tachycardia (3 to 32 beats) with heart rates of 1I0
to 230 beats/min. Twenty percent were noted to have ven-
tricular pairs. No correlation was noted between clinical
symptoms or degree of left ventricular dysfunction and the
number of ventricular pairs or episodes of ventricular tachy-
cardia. Nineteen patients died during the period of obser-
vation, 7 from congestive heart failure and 12 from sudden
death. Patients who died suddenly had significantly more
episodes of ventricular tachycardia, pairs or total ventricular
premature complexes compared with survivors and those
who died from congestive heart failure. A linear stepwise
discriminant function analysis using hemodynamic and ar-
rhythmic variables resulted in a meaningful separation be-
tween survivors and patients who died suddenly or from
congestive heart failure. Those patients with dilated cardio-
myopathy and reduced left ventricular ejection fraction «
40%) in whom frequent pairs or ventricular tachycardia were
detected with 24 hour monitoring were at high risk of sudden
death. Meinertz et aI. (15) consequently suggest that these
findings warrant consideration of antiarrhythmic treatment
despite lack of evidence that it will prevent sudden death.
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